» Articles » PMID: 37052871

Valproic Acid Radiosensitizes Anaplastic Thyroid Cells Through a Decrease of the DNA Damage Repair Capacity

Overview
Publisher Springer
Specialty Endocrinology
Date 2023 Apr 13
PMID 37052871
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anaplastic thyroid cancer (ATC) represents a rare lethal human malignancy with poor prognosis. Multimodality treatment, including radiotherapy, is recommended to improve local control and survival. Valproic acid (VA) is a clinically available histone deacetylase inhibitor with a well-documented side effect profile. In this study, we aim to investigate the combined effect of VA with photon irradiation in vitro.

Methods: Anaplastic thyroid cancer cells (8505c) were used to investigate the radiosensitizing effect of VA.

Results: VA sensitized cells to photon irradiation. VA increased radiation-induced apoptosis and radiation-induced DNA damage measured by γH2AX foci induction. Furthermore, VA prolonged γH2AX foci disappearance over time in irradiated cells and decreased the radiation-induced levels of mRNA of key DNA damage repair proteins of the homologous recombination (HR) and the nonhomologous end joining (NHEJ) pathways.

Conclusions: VA at a clinically safe dose enhance the radiosensitivity of 8505c cells through an increase in radiation-induced apoptosis and a disruption in the molecular mechanism of HR and NHEJ DNA damage repair pathways.

Citing Articles

NOTCH1 regulates the DNA damage response and sorafenib resistance by activating ATM in hepatocellular carcinoma.

Liu J, Yu Y, Xu B, Liang Q, Fang T, Zhou N Am J Transl Res. 2025; 16(12):7317-7329.

PMID: 39822534 PMC: 11733373. DOI: 10.62347/EAFU3015.

References
1.
Veness M, Porter G, Morgan G . Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach. ANZ J Surg. 2004; 74(7):559-62. DOI: 10.1111/j.1445-2197.2004.03062.x. View

2.
Smallridge R, Ain K, Asa S, Bible K, Brierley J, Burman K . American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012; 22(11):1104-39. DOI: 10.1089/thy.2012.0302. View

3.
Busnardo B, Daniele O, Pelizzo M, Mazzarotto R, Nacamulli D, Devido D . A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients. J Endocrinol Invest. 2001; 23(11):755-61. DOI: 10.1007/BF03345066. View

4.
Haigh P, Ituarte P, Wu H, Treseler P, Posner M, Quivey J . Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer. 2001; 91(12):2335-42. View

5.
Stavas M, Shinohara E, Attia A, Ning M, Friedman J, Cmelak A . Short course high dose radiotherapy in the treatment of anaplastic thyroid carcinoma. J Thyroid Res. 2014; 2014:764281. PMC: 4213987. DOI: 10.1155/2014/764281. View